WSLHD
Skip navigation
Please use this identifier to cite or link to this item: https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8383
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRauff, Bisma-
dc.contributor.authorRamezani-Moghadam, Mehdi-
dc.contributor.authorTay, Enoch S.-
dc.contributor.authorGeorge, Jacob-
dc.contributor.authorDouglas, Mark W.-
dc.date.accessioned2024-01-23T01:00:21Z-
dc.date.available2024-01-23T01:00:21Z-
dc.date.issued2023-
dc.identifier.citationFuture Virology 18(12):757-766, 2023-
dc.identifier.urihttps://wslhd.intersearch.com.au/wslhdjspui/handle/1/8383-
dc.description.abstractAIM: To investigate the mechanism of liver fibrosis in chronic hepatitis C virus (HCV) infection we developed an in vitro model. METHODS: Huh7 cells were transfected with HCV (JFH1 or Jc1) or sub-genomic replicons and expression of pro-fibrotic cytokines determined by qPCR. Media from infected cells was transferred onto LX2 cells or primary rat stellate cells and expression of pro-fibrotic genes measured by qPCR. RESULTS: Replication competent HCV, but not sub-genomic replicons, induced expression of TGF-beta1 and CTGF. Supernatant from infected cells induced alpha-SMA and COL1A1 expression and stellate cell migration, confirming functional activation. CONCLUSIONS: Infected cells produce pro-fibrogenic cytokines TGF-beta1 and CTGF and activate stellate cells. This mechanism could be targeted to prevent or treat HCV-induced fibrosis.-
dc.subjectInfections-
dc.subjectHepatology-
dc.titleDevelopment of an in vitro model to study hepatitis C virus-induced fibrosis-
dc.typeJournal Article-
dc.identifier.doihttps://dx.doi.org/10.2217/fvl-2022-0206-
dc.subject.keywordscell migration-
dc.subject.keywordsHepatitis C-
dc.identifier.journaltitleFuture Virology-
dc.identifier.departmentWestmead Institute for Medical Research-
dc.identifier.departmentGastroenterology and Hepatology-
dc.identifier.departmentPathology-
dc.identifier.departmentInfectious Diseases-
dc.contributor.wslhdRauff, Bisma-
dc.contributor.wslhdRamezani-Moghadam, Mehdi-
dc.contributor.wslhdTay, Enoch S.-
dc.contributor.wslhdGeorge, Jacob-
dc.contributor.wslhdDouglas, Mark W.-
dc.type.studyortrialControlled Study-
dc.identifier.affiliationStorr Liver Centre, Westmead Institute for Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW, Australia-
dc.identifier.affiliationCentre for Infectious Diseases and Microbiology, Sydney Infectious Diseases Institute, University of Sydney, Westmead Hospital, Westmead, NSW, Australia-
dc.identifier.facilityBlacktown-
dc.identifier.facilityWestmead-
Appears in Collections:Blacktown Mount Druitt Hospital

Files in This Item:
There are no files associated with this item.


Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.